Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

NICE has recommended Vanflyta (quizartinib) for routine NHS commissioning as an induction, consolidation, and maintenance ...

A recent UPC ruling involving Novartis has major implications for determining jurisdiction, claim interpretation and imminent ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

Iberdrola O: 8; L: 8; I: 8; Total: 24 In November 2023, the energy group’s legal team launched a pro-bono programme to ...

On the client side, there were three pharma companies at the top of the leader board. Novartis (including Novartis and ...

If you want best-in-class health and wellness destinations, look no further than the clinics of Switzerland. You’ll find your ...

This is the sort of success story the EU likes to tell about itself. Europe is home to the world’s least corrupt countries, ...

The twice-a-year jab , called inclisiran, was approved for use on the NHS in 2021 for patients with stubbornly high cholesterol levels who have already suffered a heart attack.

Our study shows the feasibility of real-time estimation of antibody kinetics before SARS-CoV-2 variant emergence. This estimation is valuable for understanding how specific combinations of SARS-CoV-2 ...

The limitations of currently available therapies for immune thrombocytopenia (ITP) mean that long-term responses are ...